Evidence map›Paper›PMID 27331041›Full record

ArticleMuscles, ligaments and tendons journal

Efficacy of betamethasone valerate medicated plaster on painful chronic elbow tendinopathy: a double-blind, randomized, placebo-controlled trial.

Antonio Frizziero, Araldo Causero, Stefano Bernasconi, Rocco Papalia, Mario Longo, Vincenzo Sessa, Francesco Sadile, Pasquale Greco, Umberto Tarantino, Stefano Masiero and 2 more

Open access · greenAbstract read
In one paragraph

Article in Muscles, ligaments and tendons journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Antonio FrizzieroDepartment of Physical and Rehabilitation Medicine, University of Padova, Padova, Italy.
Araldo CauseroOrthopaedics Clinic, "Santa Maria Misericordia" University Hospital, Udine, Italy.
Stefano BernasconiOrthopaedics and Traumatology Unit, General Hospital, Legnano (MI), Italy.
Rocco PapaliaOrthopaedics and Traumatology Unit, Campus Bio-Medico University, Rome, Italy.
Mario LongoOrthopaedics and Traumatology Unit, General Hospital, Pavullo nel Frignano (MO), Italy.
Vincenzo SessaOrthopaedics and Traumatology Unit, "San Giovanni Calibita Fatebenefratelli" Hospital, Rome, Italy.
Francesco SadileDepartment of Orthopaedic Surgery, University Federico II, Naples, Italy.
Pasquale GrecoOrthopaedics and Traumatology Unit, "Sant'Anna e San Sebastiano" Hospital, Caserta, Italy.
Umberto TarantinoOrthopaedics and Traumatology Department, "Tor Vergata" University Hospital, Rome, Italy.
Stefano MasieroDepartment of Physical and Rehabilitation Medicine, University of Padova, Padova, Italy.
Stefano RovatiIBSA Institut Biochimique SA, Pambio-Noranco, Switzerland.
Valeria FrangioneIBSA Institut Biochimique SA, Pambio-Noranco, Switzerland.
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveto investigate the efficacy and safety of a medicated plaster containing betamethasone valerate (BMV) 2.25 mg in patients with chronic elbow tendinopathy.

methodsrandomized, double-blind, placebo-controlled study with assignment 2:2:1:1 to BMV medicated plaster applied daily for 12 hours, daily for 24 hours or matched placebo. 62 patients aged ≥18 years with chronic lateral elbow tendinopathy were randomized. The primary efficacy variable was pain reduction (VAS) at day 28. Secondary objectives included summed pain intensity differences (SPID), overall treatment efficacy and tolerability.

resultsmean reduction in VAS pain score at day 28 was greater in both BMV medicated plaster groups, -39.35±27.69 mm for BMV12-h and -36.91±32.50 mm for BMV24-h, than with placebo, -20.20±27.32 mm. Considering the adjusted mean decreases, there was a statistically significant difference between BMV12-h and placebo (p=0.0110). Global pain relief (SPID) and overall treatment efficacy were significantly better with BMV. BMV and placebo plasters had similar local tolerability and there were few treatment-related adverse events.

conclusionsBMV plaster was significantly more effective than placebo at reducing pain in patients with chronic elbow tendinopathies. The BMV plaster was safe and well tolerated.

Indexed as

betamethasone valeratechronic elbow tendinopathypaintopical corticosteroidstreatment

Identifiers

PMID27331041
PMCPMC4915452
OpenAlexW2399619981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.